ArticleBMC medicine2026
Spatial characterization of intrahepatic fat deposition across steatotic liver disease subcategories: a multicenter study.
Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The spatial heterogeneity of intra-pancreatic fat deposition in children and adolescents with obesity.European journal of pediatrics · 2026Article
- A dose-response study of the association between MRI-derived liver proton density fat fraction and prevalent T2DM in postmenopausal women with abnormal glucose metabolism.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundIntrahepatic fat accumulation presents spatial heterogeneity, potentially varying across steatotic liver disease (SLD) subcategories. Current whole-liver spatial profiling remains limited. In this study, we systematically evaluated spatial fat distribution patterns in metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and SLD with chronic hepatitis B (SLD&CHB) using a fully automated nnU-Net model for whole-liver segmentation and two-point Dixon MRI-based fat fraction mapping.
methodsThis multicenter retrospective study included the analysis of 682 patients with hepatic steatosis (MASLD: 451; ALD: 89; SLD&CHB: 142) who underwent two-point Dixon MRI. The fully automated nnU-Net-based MRI framework was developed with in-phase (IP), out-phase (OP), water, and fat images, and the model performance was quantified using the Dice similarity coefficient (DSC) score. The fat fraction (FF), standard deviation of FF (SD-FF), lobar asymmetry, and periportal-to-peripheral gradients were compared across SLD subcategories and steatosis severity levels (L1: mild, L2: moderate, L3: severe).
resultsThe segmentation model achieved: whole-liver DSC: 0.94; left lobe DSC: 0.94; right lobe DSC: 0.96. Compared with ALD and SLD&CHB, MASLD exhibited the highest fat burden (FF: 16.29%) and greatest spatial heterogeneity (SD-FF: 8.22). FF was significantly higher in the right lobe than in the left lobe in MASLD and ALD (both P < .05), whereas no significant lobar difference was observed in SLD&CHB. SD-FF was consistently higher in the left lobe across all SLD subcategories (P < .001), indicating greater heterogeneity of fat distribution in the left lobe. Periportal-to-peripheral gradient analysis revealed peripheral fat enrichment in MASLD and ALD, while the opposite trend in SLD&CHB.
conclusionsThis study developed a fully automated quantification model for the spatial distribution of whole-liver fat. Characterization of the spatial heterogeneity of hepatic fat accumulation provides additional, phenotypically relevant information across SLD subcategories. These findings highlight the clinical utility of spatial heterogeneity as a novel, noninvasive imaging biomarker for subtype identification and personalized disease assessment of SLD. Moreover, this automated framework offers a scalable and objective tool for future longitudinal monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.